FDAClass IIJune 8, 2016

LGD-Xtreme recall

LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL

Why was LGD-Xtreme recalled?

Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # 21511166, Exp 11/18

Product
LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL
Recalling firm
Invisiblu International LLC
Quantity
3,319 bottles
Distribution
Nationwide and Brazil.
Recall date
June 8, 2016
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls